Pedro Bargão Santos, MD, PhD

Uro-Oncology | MD | PhD | FEBU | Minimally invasive surgery - robotic, laparoscopic, endoscopic @ Hospital Prof. Doutor Fernando Fonseca @ CUF Hospital

[HUCAD Courses @UrologyHucad]

6th Edition of the HUCAD Laparoscopic Urology

👍 Prostate Day - Hands-on👌

👤Faculty: @EstevaolimaLima, Pedro Bargão, @FredericoTeves, João Dores, Daniel Oliveira, Afonso Castro and @nunodomingues87

@Uroweb
@apurologia
@AhedPT
Nova Medical School

[Pedro Bargão Santos, MD, PhD @PedroBargao]

Acabei de publicar uma foto em Praça do Marquês de Pombal https://t.co/9xpvzCjdZI

[AIS Medical Network. @AISMedicalNet]

Laparoscopic Simple Prostatectomy with Prostatic Urethra Preservation for Benign Prostatic Hyperplasia: https://t.co/jAR6IlrRHq by André Barcelos, MD, António Pinheiro, MD, @PedroBargao, PhD, Hospital Prof. Doutor Fernando Fonseca & Estevão Lima, PhD, Hospital CUF Tejo

[Pedro Bargão Santos, MD, PhD @PedroBargao]

#cuftejo #firstlaparoscopicradicalnephrectomy with Dr Ferrito and Dr António Pinheiro #greathospital

[Pedro Bargão Santos, MD, PhD @PedroBargao]

https://t.co/Fk5EIdRcCi

[Pedro Bargão Santos, MD, PhD @PedroBargao]

This was the main contribution of my thesis! https://t.co/37LuMoZlBZ

[Pedro Bargão Santos, MD, PhD @PedroBargao]

https://t.co/9jiPh9IyQd

[Pedro Bargão Santos, MD, PhD @PedroBargao]

PhD done! @NOVAunl NOVA Medical School - Thank you to the supervisors Professors Rui Henrique, Ana Félix and Hiten Patel, and to the jury: Professors Miguel Xavier, La Fuente de Carvalho, António Lopez-Beltran, @LuisCP, @RicardoLeao_MD, Hiten Patel. 👍🏼

[Pedro Bargão Santos, MD, PhD @PedroBargao]

Today

[Pedro Bargão Santos, MD, PhD @PedroBargao]

https://t.co/s14ygQrk4B

[Pedro Bargão Santos, MD, PhD @PedroBargao]

@Ric_Campi @MaartenAlbersen @AndreaNecchi @GGandaglia @andrearussouro @_alelarcher @foxal72 Thank you Riccardo! Good luck 👊🏻

[Pedro Bargão Santos, MD, PhD @PedroBargao]

@Ric_Campi @MaartenAlbersen @AndreaNecchi @GGandaglia @andrearussouro @_alelarcher @foxal72 Hi Riccardo! Are you testing those elective patients for Covid19? Thank you. Warm regards

[Yao Zhu @yao_zhu_sh]

China CDC: Multilingual epidemic control manuals for COVID-19

https://t.co/bep0dOGIov

[Bernardo Lobão Teixeira @Bernardolobao2]

Converting a non invasive ventilator intoninvasive ventilation. Brilliant work and engineering by Dr. Paulo Roberto, Anesthesiologist at Centro Hospitalar VN Gaia, Portugal. Potentially live saving!!
#COVID2019 #intensivecare #macgyvercare #Ventilators

https://t.co/ualTUrVEyU

[European Association of Urology (EAU) @Uroweb]

Offer AS and possibly delayed SRT to patients with biochemical recurrence (BCR) and favourable prognostic factors (≤ pT3a, time to BCR > three years, PSA-DT > twelve months, GS ≤ 7), who may not benefit from intervention.

#eauguidelines #prostatecancer

https://t.co/bfkImm1Hkl

[Pedro Bargão Santos, MD, PhD @PedroBargao]

3rd Human Cadaveric Advanced Laparoscopic 3D Urology Postgraduate Course - 3rd HUCAD LAP 3D Urology
@UrologyHucad
With @nunodomingues87
@shekharbiyani
@NOVAunl Faculdade de Ciências Médicas de Lisboa

[Pedro Bargão Santos, MD, PhD @PedroBargao]

https://t.co/dvSjMNE4vc
#IMDC criteria calculator Metastatic #kidneycancer risk group https://t.co/JmYevtuhaM

[Kirsten Greene @KGUROmd]

Is this the best GU ASCO ever or does it just feel like it because I’m not there and missing out? #GU20 So many impactful abstracts. @CChuMD

[Neeraj Agarwal, MD, FASCO @neerajaiims]

Very pleased to report exciting objective responses with Cabozantinib + Atezolizumab in mCRPC with progressive measurable disease, after prior abi and/or enza. 32% ORR, additional 48% SD, clinical benefit in 80% pts. Duration of response ~8 mo. #GU20 @ASCO @montypal @DrChoueiri

[Michael Staehler @MichaelStaehler]

One of the best talks on shared decision making in small renal masses based on data of 5300 pt. ⁦@spsutkaMD⁩ #GU20. Impressive data - impressive colleague